Metabolic Effects of JAK1/2 Inhibition in Patients with Myeloproliferative Neoplasms
Source: Sapre M, Tremblay D, Leiter A, et al. SAT-091 Metabolic Effects of JAK1/2 Inhibition in Patients with Myeloproliferative Neoplasms. Journal of the Endocrine Society, Volume 3, Issue Supplement 1, April-May 2019. DOI: 10.1210/js.2019-SAT-091
Published
Please sign in or register for FREE
Sign in to OnMedica
Or sign in via
Are you a GP or Specialist Doctor, practising in UK, looking for:
- easy-to-digest, relevant updates and educational content
- a safe-space to share and collaborate with peers?
OnMedica is for you, sign up FOR FREE now!
No comments yet.